Home Headline News The Street’s Key Stock Analysts Research Reports

The Street’s Key Stock Analysts Research Reports

96
0

$ACAD, $ADBE, $BSX, $GS, $ICE, $NDAQ, $VRTX

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of The Street’s Key analysts outlook for Key issues for Tuesday, as follows:

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) was started as Buy with a 60 target price at Guggenheim.

Adobe Inc. (NASDAQ:ADBE) was reiterated as Buy and its target price was raised to 368 at Argus.

Boston Scientific Corp. (NYSE:BSX) was reiterated as Overweight and its target price was raised to 52 at Wells Fargo.

Goldman Sachs Group Inc. (NYSE:GS) was raised to Buy from Neutral with a 255 target price at Citigroup.

Intercontinental Exchange Inc. (NYSE:ICE) was started as Outperform at Credit Suisse.

Nasdaq Inc. (NASDAQ:NDAQ) was started as Outperform at Credit Suisse.

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) was reiterated as Buy and the target price was raised to 248 at Argus.

Stay tuned…

Previous articleSeeing This Bull Market Extending into 2020, Not ‘Melting-up’
Next articleWill Bitcoin: USD/BTC (BTC=X) drop further soon?
S. Jack Heffernan Ph.D. Economist at Knightsbridge holds a Ph.D. in Economics and brings with him over 25 years of trading experience in Asia and hands on experience in Venture Capital, he has been involved in several start ups that have seen market capitalization over $500m and 1 that reach a peak market cap of $15b. He has managed and overseen start ups in Crypto, Mining, Shipping, Technology and Financial Services.